Financial comparisons Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE 01:30:00 29/09/2026 am IST			5-day change	1st Jan Change
2.500 ^USD	-0.79%		-15.82%	-9.09%

21/09	Perspective Therapeutics, Inc.(NYSEAM:CATX) dropped from S&P Biotechnology Select Industry Index	CI
18/09	William Blair Initiates Perspective Therapeutics With Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
PERSPECTIVE THERAPEUTICS, INC.	9L	-11,665.27%	-12,846.61%	-41.44%	-	1.3x
LONZA GROUP AG	823.63Cr	14.53%	21.7%	10.28%	4.9%	1.58x
IQVIA HOLDINGS INC.	1.63TCr	8.34%	13.38%	32.9%	4.79%	3.63x
BEONE MEDICINES AG	534.3Cr	5.37%	8.37%	29.84%	16.27%	-5.99x
CELLTRION, INC.	288.36Cr	24.74%	28.07%	5.94%	4.75%	1.77x
MEDPACE HOLDINGS, INC.	253.02Cr	17.83%	20.93%	70.23%	22.13%	-0.89x
TEMPUS AI, INC.	127.18Cr	-19.27%	-3.71%	-38.64%	-6.61%	-65.61x
EUROFINS SCIENTIFIC SE	856.64Cr	6.51%	14.79%	9.61%	4.34%	2.22x
ASCENDIS PHARMA A/S	85Cr	-31.67%	-18.92%	-	-	1.57x
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	401.54Cr	-3.59%	19.77%	15.46%	6.99%	1.98x
ICON PUBLIC LIMITED COMPANY	825.13Cr	2.78%	16.66%	10.62%	6.02%	1.8x
GENSCRIPT BIOTECH CORPORATION	96Cr	-55.53%	26.46%	-12.87%	-10.52%	-0.45x
BIO-TECHNE CORPORATION	121.5Cr	14.97%	31.77%	15.06%	11.79%	-0.15x
PHARMARON BEIJING CO., LTD.	201.52Cr	11.8%	13.68%	11.6%	6.52%	1.83x
KYMERA THERAPEUTICS, INC.	3.92Cr	-794.04%	-891.07%	-25.78%	-22.89%	4.75x
PROTAGONIST THERAPEUTICS, INC.	4.6Cr	-282.83%	-343.63%	-20.18%	-18.42%	0.82x
QIAGEN N.V.	209Cr	20.33%	29.46%	17.5%	10.73%	0.74x
ABIVAX	54.01L	-7,306.52%	-5,350%	-135.58%	-	2.1x
Average	359.03Cr	-1,112.86%	-1,067.16%	-2.67%	2.72%	-2.61x
Weighted average by Cap.	576.66Cr	-221.95%	-167.86%	10.45%	5.26%	-2.39x